Written by Klarity Editorial Team
Published: Apr 26, 2026

If you’re a psychiatrist or PMHNP considering telepsychiatry for depression treatment, you’re probably asking: Can I legally prescribe antidepressants and other psychiatric meds remotely? What are the rules in my state? And does my provider type (MD vs NP) matter?
The short answer: Yes, treating depression via telehealth is widely permitted — but the details depend heavily on your credentials and where your patient is located.
This guide breaks down exactly what psychiatrists and PMHNPs can do when managing depression medications through telehealth platforms like Klarity Health, with state-specific requirements for California, Texas, Florida, New York, Pennsylvania, and Illinois.
Depression care is uniquely suited to telehealth for a few key reasons:
First-line medications aren’t controlled substances. SSRIs, SNRIs, and most other antidepressants fall outside DEA scheduling. Unlike ADHD or chronic pain management, you won’t hit federal controlled-substance barriers when initiating or adjusting standard depression treatment remotely. You can evaluate a patient via video, diagnose major depressive disorder, and e-prescribe a medication like sertraline or bupropion without ever needing an in-person visit.
Telehealth reimbursement is strong. Thanks to payment parity laws in most states, insurance companies reimburse telehealth medication management visits at the same rate as office visits. As of 2025, 44 states plus DC mandate private insurance coverage for telehealth, and 23 states explicitly require equal payment for virtual care. A 30-minute medication follow-up (CPT 99214) typically reimburses around $120–130 from major insurers — whether you’re face-to-face or on video.
The clinical workflow translates well. Mental status exams, suicide risk assessments, and symptom monitoring (using tools like the PHQ-9) can all be conducted effectively via secure video. You can schedule frequent brief check-ins during the first 8–12 weeks of antidepressant treatment to monitor side effects and response — something that’s actually easier with telehealth since patients don’t need to take time off work or arrange transportation.
Patient demand is enormous. States like Texas and Florida face severe psychiatrist shortages (roughly 1 psychiatrist per 8,500–9,000 residents), leaving hundreds of thousands of people with untreated depression. Telehealth lets you reach these underserved populations without the overhead of opening satellite offices.
If you’re a board-certified psychiatrist (MD or DO), your prescriptive authority for depression is unrestricted as long as you hold an active license in the state where the patient is physically located during the telehealth session.
Scope of practice: You can evaluate, diagnose, and prescribe any medication indicated for depression — SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants, mood stabilizers, antipsychotics for treatment-resistant depression, even controlled substances like benzodiazepines or stimulants when clinically appropriate.
No collaborative agreements needed: Unlike nurse practitioners in many states, psychiatrists never require physician oversight or supervision. Your medical license is your authority.
Multi-state practice: The Interstate Medical Licensure Compact (IMLC) now includes 37 states, providing a streamlined pathway to obtain licenses across state lines. This is critical for telehealth — you can treat patients in any state where you hold licensure, dramatically expanding your reach.
While most depression treatment doesn’t involve controlled substances, you may occasionally need to prescribe a benzodiazepine for severe anxiety, a stimulant for depression-related fatigue, or sleep aids for insomnia comorbid with depression.
Current federal rules (extended through end of 2025): The DEA has continued COVID-era flexibilities allowing psychiatrists to prescribe controlled substances via telehealth without an initial in-person examination. This means you can legally prescribe Schedule II–V medications to established telehealth patients nationwide under temporary regulations.
What happens after 2025? The DEA and HHS are working on permanent telemedicine prescribing rules. Given bipartisan support for tele-mental health and the proven outcomes during the pandemic, most experts expect the final regulations will preserve some form of remote controlled substance prescribing for psychiatric care.
State variations: A handful of states had their own teleprescribing restrictions pre-pandemic, but most aligned with federal flexibilities. Texas and Michigan, for example, have long permitted controlled substance prescribing for mental health treatment via telemedicine under proper protocols.
Telehealth doesn’t lower the bar — you’re held to the same standard of care as in-person practice:
Electronic prescribing systems make this seamless. After your video visit, you send prescriptions directly to the patient’s local pharmacy. You can also order labs (like TSH to rule out hypothyroidism contributing to depression) with patients getting bloodwork done at local facilities.
Medicare: Federal legislation has extended telehealth coverage for mental health services through at least September 2025, with likely further extensions. Medicare pays psychiatrists the Physician Fee Schedule rate for telehealth E/M visits — around $115 for a 99214 (30-minute moderate-complexity visit), $80 for a 99213 (15-minute visit).
Private payers: Most commercial insurers reimburse telehealth psychiatric visits at parity with office visits thanks to state laws. In New York and Illinois, for example, parity is mandated by statute. Even in states without explicit mandates, behavioral health telehealth is widely reimbursed given the Mental Health Parity Act at the federal level.
Billing considerations: Use modifier 95 or GT (or Place of Service code 02) to designate telehealth. Platforms like Klarity handle this in their EHR systems. You’ll need to enroll in Medicare in each state where you treat patients and credential with insurer networks per state to maximize in-network reimbursement.
For Psychiatric Mental Health Nurse Practitioners, prescribing authority varies dramatically by state. Unlike psychiatrists who have universal authority via their medical license, PMHNPs practice under nursing regulations that range from full independence to strict physician oversight.
States fall into three categories:
Full Practice: NPs can evaluate, diagnose, and prescribe without physician collaboration (New York, California by 2026)
Reduced Practice: NPs need a collaborative agreement or physician involvement for certain aspects, typically prescribing (Pennsylvania, Illinois for those without FPA status)
Restricted Practice: NPs must have continuous physician supervision (Texas, Florida for psychiatric NPs)
New York — Full Independence
New York became a full practice state in 2022. After completing 3,600 hours of practice, PMHNPs can prescribe independently without any collaborative agreement. The Nurse Practitioner Modernization Act eliminated the written collaboration requirement entirely.
What this means: A PMHNP in New York treating depression via telehealth has essentially the same prescriptive authority as a psychiatrist. You can initiate SSRIs, adjust dosages, switch medications, and manage the full spectrum of depression treatment without physician oversight.
The catch: Medicare still reimburses NPs at 85% of the Physician Fee Schedule rate (about $98 vs $115 for a 99214), so there’s a slight reimbursement differential compared to MDs.
California — Transitioning to Full Practice
California’s AB 890 law is phasing in NP independence. As of 2023, qualified NPs can practice without standardized procedures (physician protocols) in certain healthcare settings. By January 1, 2026, experienced NPs meeting certification requirements can practice fully independently even outside those settings.
What this means for depression care: If you’re an experienced PMHNP who has completed the Board’s certification process, you can evaluate and prescribe for depression patients in California without a collaborating physician — essentially operating like a psychiatrist. Until you obtain that certification, California’s old ‘standardized procedures’ requirement still applies, meaning you’d need an MD to oversee your prescribing.
Timeline: The transition is happening now. By 2026, most established PMHNPs in California will have full autonomy.
Texas — Strict Physician Oversight Required
Texas remains a restricted practice state with no changes on the horizon. PMHNPs must have a formal Prescriptive Authority Agreement with a supervising physician who conducts periodic chart reviews and maintains availability for consultation.
What this means: You cannot prescribe any medication — including basic antidepressants — without a delegating physician. The supervising MD doesn’t need to be on-site for telehealth visits, but the oversight structure must be documented and maintained per Texas Board rules.
Additional limits: Texas generally prohibits NP prescribing of Schedule II controlled substances in outpatient settings (exceptions for hospital-based or hospice care).
For telehealth platforms: This means Klarity or any other service operating in Texas would need to provide physician supervision for PMHNP providers. Psychiatrists (MDs) have a clear operational advantage in Texas given they can practice independently.
Florida — Psychiatric NPs Still Restricted
Florida created an ‘autonomous APRN’ category in 2020, but it applies only to primary care specialties — family practice, pediatrics, internal medicine, and midwifery. Psychiatric NPs were explicitly excluded.
What this means: PMHNPs in Florida must still practice under a written protocol with a supervising physician. You can prescribe antidepressants and other psychiatric medications, including controlled substances with limits (benzodiazepines, sleep aids), but only under that physician’s delegation.
Controlled substance notes: Florida allows NP controlled substance prescribing for mental health but limits Schedule II prescriptions for acute pain to 7 days. For depression with comorbid anxiety, you could prescribe a benzodiazepine under your protocol without additional restrictions.
Pennsylvania — Collaborative Agreement Mandatory
Pennsylvania is a reduced practice state requiring PMHNPs to maintain a collaborative agreement with a physician to prescribe. The physician doesn’t co-sign every prescription, but the agreement must outline your scope and be filed with the State Board.
What this means: You can manage depression medication independently on a day-to-day basis, but you must have a collaborating physician (often a psychiatrist or family doctor) available for consultation and general oversight. The agreement typically requires periodic chart reviews.
Legislative status: Bills to grant full practice authority have been introduced but haven’t passed as of 2026.
Illinois — Full Practice Available After Experience
Illinois offers a Full Practice Authority (FPA) pathway for experienced NPs. After completing 4,000 hours under a collaborative agreement plus additional training, you can apply for independent practice authority.
With FPA status: You can evaluate and prescribe for depression without routine physician collaboration. However, Illinois law still requires physician consultation (not supervision, but documented consultation) when prescribing certain controlled substances like benzodiazepines or Schedule II stimulants.
Without FPA status: You need a written collaborative agreement with a physician for all prescribing.
What this means for depression treatment: An experienced Illinois PMHNP with FPA can manage standard antidepressant therapy fully independently. If treatment involves controlled adjuncts, you’d need to consult with an MD but can still prescribe under your own authority.
Here’s where provider recruitment gets real: How do you actually get patients, and what does it cost?
Many providers think they’ll build a telehealth practice through SEO, Google Ads, or directory listings. The economics rarely work:
SEO takes 6–12 months of consistent investment before generating meaningful patient flow. You’re paying a consultant $2,000–5,000/month with no guarantee of results, competing against established practices and national platforms.
Google Ads for mental health keywords run $15–40+ per click, and most clicks don’t convert to booked patients. Factor in campaign testing, optimization, and no-shows from cold leads — realistic cost per booked patient is $200–400+ when you include all expenses and wasted ad spend.
Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of providers on the same page. Zocdoc charges $35–100+ per booking but also has subscription costs. Total monthly marketing spend adds up fast.
The hidden costs: Your time managing campaigns, handling unqualified leads, dealing with no-shows, and the opportunity cost of seeing fewer patients while you wait for marketing to work.
Klarity uses a pay-per-appointment model similar to Zocdoc, but designed specifically for psychiatric care:
No upfront marketing spend: Zero monthly retainers, no agency fees, no ad budget gambling.
Pre-qualified patient matching: Patients are already screened for your specialty, availability, and insurance/cash-pay preference before booking. You’re not paying for tire-kickers.
Built-in telehealth infrastructure: No separate EHR, video platform, or e-prescribing system costs. Everything’s integrated.
Both insurance and cash-pay flow: Access to patients across payment models, expanding your addressable market.
You control your schedule: Only pay when a qualified patient books with you. That’s guaranteed ROI vs hoping your $5,000/month marketing spend eventually pays off.
Instead of spending $3,000–5,000/month on marketing channels with uncertain results, you pay a standard listing fee per new patient appointment. No wasted spend on clicks that don’t convert. No months of waiting for SEO to kick in. No competing with 500 other providers on a directory page.
For most providers — especially those starting out or scaling beyond their existing referral network — this eliminates the risk entirely. You know exactly what each new patient costs, and you’re only paying when you’re actually earning.
| State | MD/DO Authority | PMHNP Authority | Telehealth Notes |
|---|---|---|---|
| California | Full independent prescribing | Transitioning to full independence (complete by 2026); experienced NPs with Board certification can prescribe independently | No unique telehealth limits; AB 890 phases in NP autonomy |
| Texas | Full independent prescribing | Restricted — requires Prescriptive Authority Agreement with physician; cannot prescribe Schedule II outpatient | Telehealth allowed but NP supervision requirements still apply; severe psychiatrist shortage (1:9,000) |
| Florida | Full independent prescribing | Restricted — psychiatric NPs excluded from autonomous practice law; requires physician protocol | Allows tele-controlled substance prescribing (except chronic pain); high demand (1:8,500 psychiatrist ratio) |
| New York | Full independent prescribing | Full practice after 3,600 hours experience; no collaboration required | Strong telehealth parity laws; best supply in urban areas (1:2,900) but rural gaps |
| Pennsylvania | Full independent prescribing | Reduced practice — collaborative agreement required for all prescribing | Telehealth permitted; moderate supply (1:4,600) with rural shortages |
| Illinois | Full independent prescribing | Reduced practice with FPA option; after 4,000 hours, can get independent authority (consult needed for certain controlled substances) | Strong telehealth parity; FPA pathway makes experienced NPs nearly equivalent to MDs for depression care |
Can I prescribe antidepressants on the first telehealth visit?
Yes, if you conduct a proper psychiatric evaluation. Antidepressants are non-controlled substances, so there are no federal barriers to initiating treatment via video after establishing a patient-provider relationship. State laws recognize synchronous audio-video as sufficient for this purpose.
Do I need to see the patient in-person eventually?
Generally no, especially for ongoing depression management. However, some providers prefer an in-person visit if treatment becomes complex (e.g., severe treatment resistance, ECT consideration). It’s not legally required in most states for standard medication management.
What if I need to prescribe a controlled substance for comorbid anxiety?
Under current federal rules (extended through 2025), you can prescribe controlled substances via telehealth without an initial in-person exam. When permanent DEA rules are finalized, there may be some requirements around special registration or patient evaluation protocols, but tele-mental health is expected to retain controlled substance prescribing ability given proven outcomes.
How do I handle prescribing across state lines?
You must hold an active license in the state where the patient is physically located during the telehealth session. For psychiatrists, the Interstate Medical Licensure Compact streamlines getting multiple state licenses. For PMHNPs, you’ll need to check each state’s nursing board requirements for multi-state practice.
Can PMHNPs bill Medicare for depression treatment?
Yes, Medicare covers PMHNP services but reimburses at 85% of the Physician Fee Schedule rate. So a 99214 that pays a psychiatrist $115 would pay a PMHNP about $98. Private insurance parity varies by state.
What about malpractice insurance for telehealth?
Most malpractice carriers now cover telehealth as standard practice. Verify your policy includes telemedicine and covers you in all states where you’re licensed and practicing. Premiums are typically the same as in-person coverage.
How do I manage prescriptions across state pharmacy systems?
E-prescribing systems (integrated into platforms like Klarity) allow you to send prescriptions to any licensed pharmacy nationwide. You’ll need a DEA registration in each state where you prescribe controlled substances, but non-controlled medications only require your active medical/nursing license.
For psychiatrists, depression treatment via telehealth is operationally identical to in-person care. You have full prescriptive authority, robust reimbursement through parity laws, and the ability to expand across state lines with IMLC licensure. The main consideration is simply obtaining licenses where you want to practice.
For PMHNPs, your authority depends entirely on your state:
The telehealth opportunity is real. States face severe shortages (Texas and Florida alone need thousands more providers). Reimbursement is solid and politically protected. And the clinical model works — frequent video check-ins during antidepressant initiation may actually improve outcomes compared to quarterly office visits.
The patient acquisition challenge is also real — unless you partner with a platform that handles it for you. Spending months and thousands of dollars on DIY marketing is a gamble. Joining a network like Klarity that delivers pre-qualified patients and only charges when you see them removes that risk entirely.
If you’re licensed in any of these states (or can obtain licensure), and you’re comfortable with the scope of practice requirements for your credential type, there’s no regulatory barrier to building a successful telehealth depression practice. The demand is there. The reimbursement is there. The only question is whether you want to gamble on marketing or pay only when you’re actually earning.
California Legislative Information, AB 890 – Nurse Practitioners (Sept 29, 2020). Full text of law phasing in NP independence 2023–2026. www.leginfo.legislature.ca.gov
Florida Nurse Practitioner Association, Past New Laws – HB607 Autonomous APRN Practice (Updated 2024). Summary of Florida’s 2020 law excluding psychiatric NPs from autonomous practice. www.flanp.org
American Association of Nurse Practitioners, State Practice Environment – Texas (Accessed Feb 2026). Confirms Texas as Restricted Practice state. www.aanp.org
JD Supra / Rivkin Radler LLP, New Law Allows Experienced NPs to Practice Without a Collaborative Relationship (Apr 13, 2022). Legal analysis of New York’s 2022 NP independence law. www.jdsupra.com
Texas Nurse Practitioners Association, News Laws and Regulations – DEA Telehealth Extension (Oct 6, 2023). Federal extension of controlled substance tele-prescribing through Dec 2024. texasnp.org
Axios News, COVID Telehealth Prescribing Extended (Nov 18, 2024). Reports DEA/HHS extension through end of 2025. www.axios.com
iCanotes / Dr. October Boyles, Telehealth Parity Laws (Updated Aug 6, 2025). Overview of state telehealth coverage and payment parity (44 states + DC coverage, 23 with payment parity). www.icanotes.com
PayerPrice.com, CPT 99214 Reimbursement Rates (Verified Feb 2026). National average private insurance reimbursement data for medication management visits. payerprice.com
LegalClarity.org, Medicare Nurse Practitioner Coverage and Reimbursement (Dec 17, 2025). Explains Medicare 85% reimbursement rule for NPs citing 42 CFR 414. legalclarity.org
Healing Psychiatry Florida, Psychiatrist Shortage by State (Jan 15, 2026). State-by-state psychiatrist-to-population ratios (Texas 1:8,966, Florida 1:8,577, New York 1:2,913, etc.). www.healingpsychiatryflorida.com
Find the right provider for your needs — select your state to find expert care near you.